Combination therapy with infliximab and immunomodulators: is the glass half empty?
- PMID: 18482585
- DOI: 10.1053/j.gastro.2008.04.029
Combination therapy with infliximab and immunomodulators: is the glass half empty?
Comment on
-
Withdrawal of immunosuppression in Crohn's disease treated with scheduled infliximab maintenance: a randomized trial.Gastroenterology. 2008 Jun;134(7):1861-8. doi: 10.1053/j.gastro.2008.03.004. Epub 2008 Mar 8. Gastroenterology. 2008. PMID: 18440315 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
